Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole.

Saved in:
Bibliographic Details
Title: Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole.
Authors: Chapman JW; Canadian Cancer Trials Group Queen's University, 11 Dayman Court, Kitchener, ON, N2M 3A1, Canada. jachapma@aol.com., Bayani J; Ontario Institute for Cancer Research, Toronto, Canada.; University of Toronto, Toronto, Canada., SenGupta S; University of Toronto, Toronto, Canada.; North York General Hospital, Toronto, Canada., Bartlett JMS; University of Edinburgh, Edinburgh, UK., Piper T; University of Edinburgh, Edinburgh, UK., Quintayo MA; Ontario Institute for Cancer Research, Toronto, Canada., Virk S; Canadian Cancer Trials Group Queen's University, Kingston, Canada., Goss PE; Harvard University, Boston, MA, USA., Ingle JN; Mayo Clinic, Rochester, MN, USA., Ellis MJ; Guardant Health, Palo Alta, CA, USA., Sledge GW; Caris Life Sciences, Irving, TX, USA., Budd GT; Cleveland Clinic, Cleveland, OH, USA., Rabaglio M; Inselspital Bern, Bern, Switzerland., Ansari RH; Indiana School of Medicine, South Bend, IN, USA., Tozer R; McMaster University, Hamilton, Canada., D'Souza DP; London Regional Health Science Centre, London, Canada., Chalchal H; Alan Blair Cancer Center, Regina, Canada., Spadafora S; Algoma Regional Cancer Centre, Sault Ste Marie, Canada., Stearns V; Weill Cornell Medicine, New York, NY, USA., Perez EA; Mayo Clinic, Redwood City, CA, USA., Gelmon KA; University of British Columbia, Vancouver, Canada., Whelan TJ; McMaster University, Hamilton, Canada., Elliott C; Canadian Cancer Trials Group Queen's University, Kingston, Canada., Shepherd LE; Canadian Cancer Trials Group Queen's University, Kingston, Canada., Chen BE; Canadian Cancer Trials Group Queen's University, Kingston, Canada., Taylor KJ; University of Edinburgh, Edinburgh, UK.
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Aug; Vol. 213 (1), pp. 51-61. Date of Electronic Publication: 2025 Jun 23.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1573-7217
DOI:10.1007/s10549-025-07749-9